LOW DOSE REGIMEN AND FORMULATION OF A 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUND

ABSTRACT The present invention provides a compound of Formula I:, or a pharmaceutically acceptable salt thereof, wherein the compound of Formula I, or pharmaceutically acceptable salt thereof is administered orally with a total dose of the compound of 0.1 mg/day to 5 mg/day, useful for treating a ne...

Full description

Saved in:
Bibliographic Details
Main Authors MERGOTT, DUSTIN JAMES, KIELBASA, WILLIAM BRIAN
Format Patent
LanguageEnglish
French
Published 27.01.2022
Subjects
Online AccessGet full text

Cover

Loading…